
Hepatitis C virus (HCV-1a) E2多
抗 | Hepatitis C virus (HCV-1a) E2 Polyclonal Antibody相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Hepatitis C virus (HCV-1a) E2 Protein
- 亚型:
Polyclonal Rabbit IgG
- 保存条件:
This liquid antibody can be stored at 2℃-6510℃ for at least two weeks. Avoid repeated freeze/thaw cycles.
- 克隆性:
多克隆
- 适应物种:
IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
- 保质期:
see COA
- 库存:
大量
- 供应商:
辰辉创聚生物
- 应用范围:
ELISA
- 靶点:
Hepatitis C virus (HCV-1a) E2
- 抗体英文名:
Hepatitis C virus (HCV-1a) E2 antibody
- 抗体名:
Hepatitis C virus (HCV-1a) E2抗体
- 规格:
100ug;500ug;1mg

| 产品信息
品名:NebuSelect™ Hepatitis C virus (HCV-1a) E2 Polyclonal Antibody
货号:NBAB-106628
品牌:Nebulabio
规格:100ug;500ug;1mg
| 产品描述
| 产品属性
Product Category:Rabbit PAb
Reactivity:IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Specificity:Hepatitis C virus (HCV-1a) E2
Immunogen:Recombinant Hepatitis C virus (HCV-1a) E2 Protein
Isotype:Polyclonal Rabbit IgG
Purification:Protein A
Buffer:0.2 μm filtered solution in PBS
Conjugate:Unconjugated
Applications:ELISA
Dilution:ELISA: 1:1000-1:2000
Storage:Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
For Research Use Only!
To get more information, please contact us freely.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Hepatic carcinogenesis is a complex process that involves profound alterations of the hepatocyte genome (1,2) and has been graded in three stages: induction, promotion, and progression in the animal models (3–5). In recent years, the use
Nomenclature and Numbering of the Hepatitis C Virus
International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic
Detection and Typing of Hepatitis C Virus
For more than two decades prior to the discovery of the hepatitis C virus (HCV), posttransfusion non-A, non-B (NANB) hepatitis was thought to have a viral etiology. In 1989, the virus was finally identified through a unique application
技术资料暂无技术资料 索取技术资料







